A drive system for a drug delivery device is described. The drive system comprises an axial drive component configured to drive advancement of a stopper sealing a container; a variable rate drive drives advancement of the axial drive component and a controller controls the variable rate drive to deliver a first volume of medicament at a first rate, and a second volume of medicament at a second rate. The controller is configured to: optionally, identify a start point for delivery of medicament from the container, the start point being identified as completion of a predefined preparatory event; drive the variable rate drive at a first speed during a first phase from the identified start point to deliver the first volume of medicament at the first rate; drive the variable rate drive at a second speed during a second phase to deliver the second volume of medicament at the second rate.

A method, system, and computer program product are disclosed for performance monitoring of a smart fluid injector system having at least one sensor configured for detecting operation data. The operation data includes one or more operation parameters associated with at least one of: one or more drive components of the fluid injector system and at least one disposable component configured for use with the fluid injector system. The fluid injector system further includes a control device having at least one processor programmed or configured to: receive the operation data, and determine a component status for at least one of: the drive component(s), the disposable component(s), and administration line(s) by comparing the received operation data with stored operation data. The component status includes one or more predictions of an operation failure or a misuse of at least one of: the drive component(s), the disposable component(s), and administration line(s).

A system and method for calibrating an IV pump infusion system tube comprises a fluid source, an infusion system comprising, an IV pump, a drive unit, a chamber with known constant volume, a control unit, and IV tubing with a known inner diameter tolerance, and a switch and magnetic floating object. The system administers medicinal fluid, calculates the flow rate of the medicinal fluid in the chamber by measuring the time the switch is activated as medicinal fluid rises in the chamber, compares the calculated flow rate with a set flow rate of the IV pump input in the control unit prior to infusion, and adjusts the IV pump and flow rate based on the compared deviations for more accurate delivery to a patient. This configuration may provide a more precise delivery rate of medicinal fluid, preventing harm to the patient and waste of medicine.

An enzymatic sensor configured to determine the concentration of levodopa present in a sample according to a current or a resonant frequency produced in response to levodopa interactions with L-amino acid decarboxylase present in the sensor. A processor associated with the sensor determines levodopa concentration and produces dose recommendation or output according to levodopa concentration.

Various techniques for facilitating communication with and across a clinical environment and a cloud environment are described. For example, a method for authenticating a network device residing in the clinical environment using a token is described. An authentication proxy in the cloud environment can receive a request from a connectivity adapter in the clinical environment and retrieve a security token from an authentication system in the cloud. The connectivity adapter can use the security token to send signed requests to the authentication system.

Systems and methods are disclosed herein for providing a configuration code for customizing a glucose level control system for at least an initial period. The configuration code can be based on one or more dosing parameters from a tracked medicament therapy administered to a subject over a tracking period by the glucose level control system. The configuration code includes encoded dosing parameters including a correction dosing parameter based on at least some of the correction boluses of medicament administered during the tracking period, a food intake dosing parameter comprising an indication of a food intake bolus size of medicament based on one or more food intake boluses provided during the tracking period, and a basal dosing parameter based on at least some of the basal doses of medicament administered during the tracking period.

A system and a method for management of diabetes are provided. The system includes an infusion pump, glucose sensor, and controller that is programmed to control insulin delivery based upon at least one stored variable. The controller calculates a maximum insulin delivery rate based on the default basal insulin delivery rate, temporary basal insulin delivery rate, extended bolus rate, or a combination thereof.

Medical devices and related patient management systems and methods are provided. A method of presenting information pertaining to operation of a medical device involves obtaining historical glucose measurement data for a patient from a database, identifying, based on the historical glucose measurement data, a first set of event patterns within respective ones of a plurality of monitoring periods, obtaining an adjusted set of glucose measurement data determined based on the historical glucose measurement data and an uncertainty metric associated with the historical glucose measurement data, identifying, based on the adjusted set of glucose measurement data, one or more event patterns within respective ones of the plurality of monitoring periods, and generating a graphical user interface display comprising an event detection region based at least in part on the first plurality and the one or more sets of event patterns.

Ambulatory medical devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can transmit a request to modify blood glucose control therapy delivered to a subject. The request can be transmitted via a voice-activated control system, the ambulatory medicament pump can include a medicament reservoir, a pump controller, a wireless data interface, and/or other elements. The device can receive an indication that the request to modify therapy is approved and, in response to the indication that the request to modify the blood glucose control therapy is approved, instruct the pump controller to modify the blood glucose control therapy delivered to the subject.

Electromechanical actuation systems and related operating methods are provided. A method of controlling an electromechanical actuator in response to an input command signal at an input terminal involves determining a commanded actuation state value based on a characteristic of the input command signal, generating driver command signals based on the commanded actuation state value and an actuator type associated with the electromechanical actuator, and operating driver circuitry in accordance with the driver command signals to provide output signals at output terminals coupled to the electromechanical actuator.